# MongoDB, Inc.: financial statements, quarterly

MDB · Nasdaq · CIK 1441816 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/mdb.md) · [Financials](/companies/mdb/financials.md) · [Filings](/companies/mdb/filings.md) · [Insiders](/companies/mdb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mdb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [433](/filings/0001441816-24-000260.md) | [458 d](/filings/0001628280-26-016799.md) | [451](/filings/0001441816-25-000118.md) | [478](/filings/0001441816-25-000181.md) | [529](/filings/0001628280-25-054768.md) | [548 d](/filings/0001628280-26-016799.md) | [549](/filings/0001628280-26-039150.md) | [591](/filings/0001628280-26-059830.md) | [628](/filings/0001628280-25-054768.md) | [695 d](/filings/0001628280-26-016799.md) | [688](/filings/0001628280-26-039150.md) | [772](/filings/0001628280-26-059830.md) |
| Cost of revenue | $m | [107](/filings/0001441816-24-000260.md) | [115 d](/filings/0001628280-26-016799.md) | [123](/filings/0001441816-25-000118.md) | [128](/filings/0001441816-25-000181.md) | [135](/filings/0001628280-25-054768.md) | [149 d](/filings/0001628280-26-016799.md) | [158](/filings/0001628280-26-039150.md) | [171](/filings/0001628280-26-059830.md) | [179](/filings/0001628280-25-054768.md) | [187 d](/filings/0001628280-26-016799.md) | [191](/filings/0001628280-26-039150.md) | [202](/filings/0001628280-26-059830.md) |
| Gross profit | $m | [326](/filings/0001441816-24-000260.md) | [343 d](/filings/0001628280-26-016799.md) | [328](/filings/0001441816-25-000118.md) | [350](/filings/0001441816-25-000181.md) | [394](/filings/0001628280-25-054768.md) | [399 d](/filings/0001628280-26-016799.md) | [391](/filings/0001628280-26-039150.md) | [420](/filings/0001628280-26-059830.md) | [449](/filings/0001628280-25-054768.md) | [508 d](/filings/0001628280-26-016799.md) | [496](/filings/0001628280-26-039150.md) | [570](/filings/0001628280-26-059830.md) |
| Research and development | $m | [128](/filings/0001441816-24-000260.md) | [146 d](/filings/0001628280-26-016799.md) | [146](/filings/0001441816-25-000118.md) | [149](/filings/0001441816-25-000181.md) | [151](/filings/0001628280-25-054768.md) | [150 d](/filings/0001628280-26-016799.md) | [169](/filings/0001628280-26-039150.md) | [182](/filings/0001628280-26-059830.md) | [177](/filings/0001628280-25-054768.md) | [189 d](/filings/0001628280-26-016799.md) | [200](/filings/0001628280-26-039150.md) | [214](/filings/0001628280-26-059830.md) |
| Operating income | $m | [(45.2)](/filings/0001441816-24-000260.md) | [(71.0) d](/filings/0001628280-26-016799.md) | [(98.2)](/filings/0001441816-25-000118.md) | [(71.4)](/filings/0001441816-25-000181.md) | [(27.9)](/filings/0001628280-25-054768.md) | [(18.6) d](/filings/0001628280-26-016799.md) | [(53.6)](/filings/0001628280-26-039150.md) | [(65.3)](/filings/0001628280-26-059830.md) | [(18.4)](/filings/0001628280-25-054768.md) | [0.3 d](/filings/0001628280-26-016799.md) | [(24.8)](/filings/0001628280-26-039150.md) | [28.4](/filings/0001628280-26-059830.md) |
| Interest expense | $m | [2.0](/filings/0001441816-24-000260.md) | [2.4 d](/filings/0001628280-26-016799.md) | [1.9](/filings/0001441816-25-000118.md) | [2.3](/filings/0001441816-25-000181.md) | [2.3](/filings/0001628280-25-054768.md) | [1.6 d](/filings/0001628280-26-016799.md) | [1.1](/filings/0001628280-26-039150.md) | [1.5](/filings/0001628280-26-059830.md) | [0.8](/filings/0001628280-25-054768.md) | [(0.2) d](/filings/0001628280-26-016799.md) | [0.9](/filings/0001628280-26-039150.md) | [0.9](/filings/0001628280-26-059830.md) |
| Income tax | $m | [3.6](/filings/0001441816-24-000260.md) | [3.4 d](/filings/0001628280-26-016799.md) | [2.6](/filings/0001441816-25-000118.md) | [3.9](/filings/0001441816-25-000181.md) | [2.7](/filings/0001628280-25-054768.md) | [(11.7) d](/filings/0001628280-26-016799.md) | [4.3](/filings/0001628280-26-039150.md) | [3.9](/filings/0001628280-26-059830.md) | [3.4](/filings/0001628280-25-054768.md) | [3.9 d](/filings/0001628280-26-016799.md) | [4.4](/filings/0001628280-26-039150.md) | [5.0](/filings/0001628280-26-059830.md) |
| Net income | $m | [(29.3)](/filings/0001441816-24-000260.md) | [(55.5) d](/filings/0001628280-26-016799.md) | [(80.6)](/filings/0001628280-25-054768.md) | [(54.5)](/filings/0001628280-25-054768.md) | [(9.8)](/filings/0001628280-25-054768.md) | [15.8 d](/filings/0001628280-26-016799.md) | [(37.6)](/filings/0001628280-26-059830.md) | [(47.0)](/filings/0001628280-26-059830.md) | [(2.0)](/filings/0001628280-25-054768.md) | [15.5 d](/filings/0001628280-26-016799.md) | [4.4](/filings/0001628280-26-059830.md) | [40.9](/filings/0001628280-26-059830.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.46)](/filings/0001628280-26-039150.md) | [(0.58)](/filings/0001628280-26-059830.md) | not reported | not reported | [0.05](/filings/0001628280-26-039150.md) | [0.50](/filings/0001628280-26-059830.md) |
| Basic EPS | $ per share | [(0.41)](/filings/0001441816-24-000260.md) | not reported | [(1.10)](/filings/0001441816-25-000118.md) | [(0.74)](/filings/0001441816-25-000181.md) | [(0.13)](/filings/0001628280-25-054768.md) | not reported | [(0.46)](/filings/0001628280-26-039150.md) | [(0.58)](/filings/0001628280-26-059830.md) | [(0.02)](/filings/0001628280-25-054768.md) | not reported | [0.06](/filings/0001628280-26-039150.md) | [0.51](/filings/0001628280-26-059830.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [478](/filings/0001441816-24-000260.md) | [803](/filings/0001628280-26-016799.md) | [816](/filings/0001441816-25-000118.md) | [1,291](/filings/0001441816-25-000181.md) | [673](/filings/0001628280-25-054768.md) | [490](/filings/0001628280-26-016799.md) | [658](/filings/0001628280-26-039150.md) | [647](/filings/0001628280-26-059830.md) | [834](/filings/0001628280-25-054768.md) | [1,084](/filings/0001628280-26-059830.md) | [1,036](/filings/0001628280-26-039150.md) | [1,002](/filings/0001628280-26-059830.md) |
| Current assets | $m | [2,321](/filings/0001441816-23-000248.md) | [2,484](/filings/0001441816-25-000057.md) | [2,652](/filings/0001441816-24-000111.md) | [2,722](/filings/0001441816-24-000188.md) | [2,794](/filings/0001441816-24-000260.md) | [2,924](/filings/0001628280-26-016799.md) | [2,973](/filings/0001441816-25-000118.md) | [2,905](/filings/0001441816-25-000181.md) | [2,932](/filings/0001628280-25-054768.md) | [3,115](/filings/0001628280-26-059830.md) | [3,060](/filings/0001628280-26-039150.md) | [3,126](/filings/0001628280-26-059830.md) |
| Total assets | $m | [2,694](/filings/0001441816-23-000248.md) | [2,870](/filings/0001441816-25-000057.md) | [3,034](/filings/0001441816-24-000111.md) | [3,131](/filings/0001441816-24-000188.md) | [3,225](/filings/0001441816-24-000260.md) | [3,430](/filings/0001628280-26-016799.md) | [3,624](/filings/0001441816-25-000118.md) | [3,542](/filings/0001441816-25-000181.md) | [3,567](/filings/0001628280-25-054768.md) | [3,759](/filings/0001628280-26-059830.md) | [3,693](/filings/0001628280-26-039150.md) | [3,778](/filings/0001628280-26-059830.md) |
| Current liabilities | $m | [490](/filings/0001441816-23-000248.md) | [564](/filings/0001441816-25-000057.md) | [537](/filings/0001441816-24-000111.md) | [541](/filings/0001441816-24-000188.md) | [1,641](/filings/0001441816-24-000260.md) | [562](/filings/0001628280-26-016799.md) | [505](/filings/0001441816-25-000118.md) | [510](/filings/0001441816-25-000181.md) | [558](/filings/0001628280-25-054768.md) | [669](/filings/0001628280-26-059830.md) | [618](/filings/0001628280-26-039150.md) | [642](/filings/0001628280-26-059830.md) |
| Total liabilities | $m | [1,726](/filings/0001441816-23-000248.md) | [1,801](/filings/0001441816-25-000057.md) | [1,765](/filings/0001441816-24-000111.md) | [1,768](/filings/0001441816-24-000188.md) | [1,723](/filings/0001441816-24-000260.md) | [648](/filings/0001628280-26-016799.md) | [591](/filings/0001441816-25-000118.md) | [599](/filings/0001441816-25-000181.md) | [678](/filings/0001628280-25-054768.md) | [806](/filings/0001628280-26-059830.md) | [758](/filings/0001628280-26-039150.md) | [798](/filings/0001628280-26-059830.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [968](/filings/0001441816-24-000260.md) | [1,069](/filings/0001628280-26-016799.md) | [1,269](/filings/0001628280-25-054768.md) | [1,363](/filings/0001628280-25-054768.md) | [1,502](/filings/0001628280-25-054768.md) | [2,782](/filings/0001628280-26-059830.md) | [3,033](/filings/0001628280-26-059830.md) | [2,943](/filings/0001628280-26-059830.md) | [2,888](/filings/0001628280-25-054768.md) | [2,952](/filings/0001628280-26-059830.md) | [2,935](/filings/0001628280-26-059830.md) | [2,980](/filings/0001628280-26-059830.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [38.4 d](/filings/0001441816-24-000260.md) | [54.6 d](/filings/0001628280-26-016799.md) | [63.6](/filings/0001441816-25-000118.md) | [(1.4) d](/filings/0001441816-25-000181.md) | [37.4 d](/filings/0001628280-25-054768.md) | [50.5 d](/filings/0001628280-26-016799.md) | [110](/filings/0001628280-26-039150.md) | [72.1 d](/filings/0001628280-26-059830.md) | [144 d](/filings/0001628280-25-054768.md) | [180 d](/filings/0001628280-26-016799.md) | [202](/filings/0001628280-26-039150.md) | [142 d](/filings/0001628280-26-059830.md) |
| Capital expenditure | $m | [2.1 d](/filings/0001441816-24-000260.md) | [2.7 d](/filings/0001628280-26-016799.md) | [0.5](/filings/0001441816-25-000118.md) | [1.1 d](/filings/0001441816-25-000181.md) | [2.0 d](/filings/0001628280-25-054768.md) | [26.0 d](/filings/0001628280-26-016799.md) | [1.6](/filings/0001628280-26-039150.md) | [0.5 d](/filings/0001628280-26-059830.md) | [1.7 d](/filings/0001628280-25-054768.md) | [1.1 d](/filings/0001628280-26-016799.md) | [2.3](/filings/0001628280-26-039150.md) | [2.5 d](/filings/0001628280-26-059830.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001628280-25-054768.md) | [0.0 d](/filings/0001628280-26-016799.md) | [0.0](/filings/0001628280-26-039150.md) | [194 d](/filings/0001628280-26-059830.md) | [149 d](/filings/0001628280-25-054768.md) | [57.3 d](/filings/0001628280-26-016799.md) | [100](/filings/0001628280-26-039150.md) | [100.0 d](/filings/0001628280-26-059830.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [81.1](/filings/0001628280-26-039150.md) | [81.1](/filings/0001628280-26-059830.md) | [81.6](/filings/0001628280-26-039150.md) | [82.0](/filings/0001628280-26-059830.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 80,556,341 at 2026-08-28, from the cover of the [10-Q filed 2026-09-01](/filings/0001628280-26-059830.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.